Yi-Kai Lo, ANEUVO – ExaStim | LSI Asia '25

ANEUVO is developing a platform technology to treat chronic injuries and conditions that do not have cures through pharmaceutical approaches. The company’s lead product, ExaStim, is a noninvasive neuromodulation system that has received Breakthrough Device Designation from the U.S. FDA for treating paralysis in patients with spinal cord injury.